Venkatesh Pilla Reddy PhD

Dr. Venkatesh Pilla Reddy is a Senior Director in the Global PKPD and Pharmacometrics group at Eli Lilly and Company in the UK. At Lilly, Venkatesh provides MIDD/PKPD Lead support for projects in oncology ADC, RLT projects, and immunology. He earned his PhD in Pharmacometrics through a collaborative program involving Pfizer, Janssen Pharmaceuticals, and Merck via TI Pharma in the Netherlands. Since then, he has made substantial contributions to the Quantitative Pharmacology and Pharmacometrics groups at Merck, AstraZeneca, and Lilly.

He was a Deputy Topic Leader at ICH, shaping the ICH M12 DDI guideline. He is playing a leading role in influential cross-industry working groups, such as IQ TALG, ISOP, ASCPT, and ISSX M&S. He also serves as an Editorial Board Member for the Biopharmaceutics and Drug Disposition Journal and is a reviewer for clinical pharmacology/PKPD M&S-related journals.